Skip to content

Category: law

CANNABINOIDS IN EPILEPSY

CANNABINOIDS IN EPILEPSY

26 February 2024

Epilepsy is one of the most common neurological disorders, affecting around 70 million people worldwide. 65% of patients are managed with antiepileptic drugs and lead a normal life but, what about the remaining 35%? These patients suffer from refractory epilepsy , signi...

robert-hoban

Robert Hoban, Global Cannabis Industry Expert.

31 January 2024

The regulation of medical cannabis in Spain could bring significant benefits to both the local and international markets. By creating a well defined legal framework, Spain would not only boost its economy but also enhance its standing in the global cannabis industry. As...

The expert opinion by Raúl Fernandez, Technical Director at Labsom

The expert opinion by Raúl Fernandez, Technical Director at Labsom

10 July 2023

Which aspect of the GMP design of a medical cannabis industry requires the most attention? I would say the most critical aspect focuses on ensuring strict control of environmental conditions. Maintaining a controlled environment is crucial to ensure product quality, saf...

The expert opinion by María Pérez Rey, R&D Project Manager at CTAEX

The expert opinion by María Pérez Rey, R&D Project Manager at CTAEX

7 June 2023

What is the importance of empirical data in the cannabis industry? The existence of sufficient scientific evidence is a recurring debate within the industry. At present, there is a duality of opinion regarding such evidence for the therapeutic use of cannabis that sugge...

Newsletter

Stay up to date with Agropharm

News about our projects, regulations and the cannabis industry. No spam: unsubscribe at any time.